MedLensLoading…
Generic name: amoxicillin
tablets), USP Veterinary Tablets · Zoetis Inc.
Dosage Form
tablets), USP Veterinary Tablets
Manufacturer
Zoetis Inc.
This medication contains important usage instructions, warnings, and side effect information that you should review before use.
Dogs: The recommended dosage is 5 mg/lb of body weight twice a day.
Cats: The recommended dosage is 50 mg (5–10 mg/lb) once a day.
Dosage should be continued for 5–7 days or 48 hours after all symptoms have subsided. If no improvement is seen in 5 days, review diagnosis and change therapy.
The use of this drug is contraindicated in animals with a history of an allergic reaction to penicillin.
Amoxicillin is a semisynthetic penicillin and has the potential for producing allergic reactions. If an allergic reaction occurs, administer epinephrine and/or steroids
Do Not Store at Temperatures Above 25°C (77°F)
Keep Bottle Tightly Closed.
Amoxi-Tabs (amoxicillin tablets) is a semisynthetic antibiotic with a broad spectrum of activity. It provides bactericidal activity against a wide range of common gram-positive and gram-negative pathogens. Chemically, it is D(-)-a-amino-p-hydroxybenzyl penicillin trihydrate.
Amoxi-Tabs are supplied in 5 strengths: 50 mg, 100 mg, 150 mg, and 200 mg in bottles of 500 tablets; 400 mg in bottles of 250 tablets.
Photos of the product and/or packaging supplied by the manufacturer.
For use in dogs and cats
Federal law restricts this drug to use by or on the order of a licensed veterinarian
Amoxi-Tabs is stable in the presence of gastric acid and may be given without regard to meals. It is rapidly absorbed after oral administration. It diffuses readily into most body tissues and fluids with the exception of brain and spinal fluid, except when meninges are inflamed. Most of the amoxicillin is excreted unchanged in the urine.
Amoxicillin is similar to ampicillin in its bactericidal action against susceptible organisms. It acts through the inhibition of biosynthesis of cell wall mucopeptide. In vitro and/or in vivo studies have demonstrated the susceptibility of most strains of the following gram-positive and gram-negative bacteria: a- and b-haemolytic streptococci, nonpenicillinase-producing staphylococci, Streptococcus faecalis, Escherichia coli, and Proteus mirabilis. Because it does not resist destruction by penicillinase, it is not effective against penicillinase-producing bacteria, particularly resistant staphylococci. All strains of Pseudomonas and most strains of Klebsiella and Enterobacter are resistant
Approved by FDA under NADA # 055-078
Approved by FDA under NADA # 055-081
zoetis
Distributed by:
Zoetis Inc.
Kalamazoo, MI 49007
P1523357
Revised: January 2020
Create a free account to view complete drug information, save medications, and more.
Free forever · No credit card required